UHA is committed to compliance with the Consolidated Appropriations Act (CAA), signed into federal law on December 27, 2020. The CAA requires employer group health plans (i.e., offered by an employer or other plan sponsor) and insurers (i.e., UHA) to report data annually regarding prescription drugs and health care spending to the federal Departments of Health and Human Services, Labor, and Treasury (Tri-Agencies) through a secure web portal.
As part of CAA’s Prescription Drug Data Collection (RxDC) reporting requirements, UHA is collecting premium information on behalf of employer / plan sponsor group health plans with UHA coverage. This includes the share paid by employees, and the employer / plan sponsor, towards their UHA monthly premium during the 2023 calendar year.
To ensure compliance with the reporting requirements, employers / plan sponsors must provide the information requested in the 2023 Calendar Year Premium Share Information form. This will help ensure UHA is able to file the required information on their behalf and that UHA and the company group health plan will be in compliance with the CAA.
Please be advised we are extending the initial due date of February 29 and requesting you provide this information for your company, no later than April 19, 2024.
UHA will submit all applicable reports and required narrative responses for all employers / plan sponsors to CMS by the June 1, 2024 deadline.
If the survey is not completed, UHA will not be able to accurately report the required data on behalf of the company group health plan. In addition, if no response to the survey is provided, the company should provide their data directly to CMS, in consultation with their own professional adviser as to the RxDC regulations and submissions requirements. Please note that UHA will not be responsible for any liability due to a company not responding to the survey or not providing the information directly to CMS.
If you have any questions, please contact your dedicated Client Services representative or the UHA Client Services Team at 808-532-4000 extension 358 or via email at [email protected].
Information regarding this federal requirement is available at https://www.cms.gov/cciio/programs-and-initiatives/other-insurance-protections/prescription-drug-data-collection.
Sincerely,
Malcolm Leong
VP of Client Services and Sales
|